ツムラの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2017/02/27 | 3,350 | 3,350 | 3,280 | 3,315 | -80 | -2.4% | 509,100 |
2017/02/24 | 3,440 | 3,450 | 3,380 | 3,395 | -60 | -1.7% | 271,600 |
2017/02/23 | 3,410 | 3,460 | 3,400 | 3,455 | +45 | +1.3% | 309,400 |
2017/02/22 | 3,400 | 3,410 | 3,370 | 3,410 | +5 | +0.1% | 213,700 |
2017/02/21 | 3,400 | 3,440 | 3,380 | 3,405 | +15 | +0.4% | 206,200 |
2017/02/20 | 3,340 | 3,395 | 3,325 | 3,390 | +50 | +1.5% | 245,800 |
2017/02/17 | 3,330 | 3,355 | 3,315 | 3,340 | -5 | -0.1% | 199,600 |
2017/02/16 | 3,340 | 3,380 | 3,330 | 3,345 | +45 | +1.4% | 307,100 |
2017/02/15 | 3,305 | 3,310 | 3,275 | 3,300 | +40 | +1.2% | 207,500 |
2017/02/14 | 3,300 | 3,300 | 3,260 | 3,260 | -40 | -1.2% | 277,900 |
2017/02/13 | 3,310 | 3,325 | 3,280 | 3,300 | ±0 | ±0% | 288,600 |
2017/02/10 | 3,245 | 3,310 | 3,210 | 3,300 | +95 | +3% | 360,100 |
2017/02/09 | 3,190 | 3,210 | 3,155 | 3,205 | -5 | -0.2% | 277,200 |
2017/02/08 | 3,180 | 3,210 | 3,110 | 3,210 | -90 | -2.7% | 618,300 |
2017/02/07 | 3,255 | 3,310 | 3,245 | 3,300 | -15 | -0.5% | 249,600 |
2017/02/06 | 3,310 | 3,315 | 3,285 | 3,315 | +5 | +0.2% | 174,800 |
2017/02/03 | 3,305 | 3,325 | 3,280 | 3,310 | +10 | +0.3% | 163,600 |
2017/02/02 | 3,300 | 3,315 | 3,265 | 3,300 | +25 | +0.8% | 271,600 |
2017/02/01 | 3,245 | 3,285 | 3,215 | 3,275 | +5 | +0.2% | 166,000 |
2017/01/31 | 3,265 | 3,290 | 3,255 | 3,270 | -10 | -0.3% | 157,200 |
2017/01/30 | 3,275 | 3,280 | 3,235 | 3,280 | +25 | +0.8% | 127,700 |
2017/01/27 | 3,270 | 3,285 | 3,250 | 3,255 | -5 | -0.2% | 115,900 |
2017/01/26 | 3,255 | 3,270 | 3,230 | 3,260 | +45 | +1.4% | 173,200 |
2017/01/25 | 3,255 | 3,255 | 3,205 | 3,215 | -35 | -1.1% | 154,000 |
2017/01/24 | 3,220 | 3,260 | 3,220 | 3,250 | ±0 | ±0% | 213,100 |
2017/01/23 | 3,240 | 3,275 | 3,220 | 3,250 | -55 | -1.7% | 134,300 |
2017/01/20 | 3,260 | 3,325 | 3,245 | 3,305 | +40 | +1.2% | 205,400 |
2017/01/19 | 3,280 | 3,285 | 3,240 | 3,265 | +5 | +0.2% | 178,600 |
2017/01/18 | 3,275 | 3,290 | 3,235 | 3,260 | -15 | -0.5% | 186,200 |
2017/01/17 | 3,310 | 3,315 | 3,250 | 3,275 | -5 | -0.2% | 225,600 |
2017/01/16 | 3,235 | 3,295 | 3,235 | 3,280 | +5 | +0.2% | 241,200 |
2017/01/13 | 3,230 | 3,280 | 3,225 | 3,275 | +40 | +1.2% | 148,800 |
2017/01/12 | 3,270 | 3,280 | 3,200 | 3,235 | -50 | -1.5% | 255,700 |
2017/01/11 | 3,295 | 3,300 | 3,270 | 3,285 | +5 | +0.2% | 128,200 |
2017/01/10 | 3,340 | 3,345 | 3,275 | 3,280 | -35 | -1.1% | 414,300 |
2017/01/06 | 3,300 | 3,315 | 3,260 | 3,315 | ±0 | ±0% | 321,500 |
2017/01/05 | 3,275 | 3,320 | 3,260 | 3,315 | +30 | +0.9% | 203,800 |
2017/01/04 | 3,285 | 3,320 | 3,255 | 3,285 | +65 | +2% | 309,700 |
2016/12/30 | 3,190 | 3,235 | 3,185 | 3,220 | +20 | +0.6% | 223,800 |
2016/12/29 | 3,245 | 3,250 | 3,180 | 3,200 | -45 | -1.4% | 184,900 |
2016/12/28 | 3,260 | 3,275 | 3,245 | 3,245 | -5 | -0.2% | 125,500 |
2016/12/27 | 3,285 | 3,310 | 3,235 | 3,250 | -30 | -0.9% | 230,500 |
2016/12/26 | 3,190 | 3,295 | 3,170 | 3,280 | +190 | +6.1% | 651,600 |
2016/12/22 | 3,170 | 3,175 | 3,060 | 3,090 | -100 | -3.1% | 477,800 |
2016/12/21 | 3,215 | 3,230 | 3,180 | 3,190 | -35 | -1.1% | 198,600 |
2016/12/20 | 3,215 | 3,240 | 3,205 | 3,225 | +25 | +0.8% | 244,700 |
2016/12/19 | 3,170 | 3,205 | 3,160 | 3,200 | +25 | +0.8% | 243,700 |
2016/12/16 | 3,150 | 3,195 | 3,150 | 3,175 | +40 | +1.3% | 234,200 |
2016/12/15 | 3,140 | 3,150 | 3,100 | 3,135 | +15 | +0.5% | 233,200 |
2016/12/14 | 3,100 | 3,155 | 3,080 | 3,120 | +65 | +2.1% | 509,300 |
2001~
2050
件表示中 / 3694件
類似銘柄と比較する
現在ご覧いただいている「ツムラ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ツムラ | 434,400円 | +20.9% | +87.3% | 3.13% | 9.70倍 | 1.11倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
久光薬 | 435,100円 | +5.8% | +1.2% | 2.76% | 14.43倍 | 1.15倍 |
|
貼る鎮痛消炎剤首位。医療用シェア5割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
住友ファーマ | 95,500円 | +26.8% | - | 0.00% | 16.08倍 | 3.32倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
ペプチド | 189,600円 | +5.0% | +1.5% | 0.00% | 16.27倍 | 4.33倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
日本新薬 | 336,400円 | +7.9% | +8.9% | 3.69% | 7.19倍 | 0.97倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
市場注目の銘柄
チャート関連のコラム